Articles by Medical News


FDA Expands Approval SPIRIVA RESPIMAT

FDA Expands Approval of SPIRIVA® RESPIMAT®

  • FDA Expands Approval of SPIRIVA® RESPIMAT®, Steroid-free Respimat now approved as asthma treatment for age 6 and older
  • Supplemental New Drug Application (sNDA) approved under priority review from the FDA
  • FDA also granted pediatric exclusivity to SPIRIVA

Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) approved SPIRIVA RESPIMAT for the long-term, once-daily maintenance treatment of asthma in people age 6 and older. SPIRIVA RESPIMAT is not a treatment for sudden asthma symptoms.



FDA Approves New Psoriasis Drug Siliq

FDA Approves New Psoriasis Drug

The U.S. FDA Approves New Psoriasis Drug Siliq (brodalumab) to treat adults with moderate-to-severe plaque psoriasis. Siliq is administered as an injection.






Hair Like Brain Implant Could Simulate Vision In The Blind

“Hair-Like” Brain Implant Could Simulate Vision In The Blind

Harvard scientists are testing a neural prosthesis that uses arrays of microscopic coils to generate magnetic fields that can target specific regions of the brain, such as the visual cortex to simulate sight. After a proof-of-concept study in mice, the researchers intend to evaluate the technology in primates and rats, and say the implant potentially could be used for nerve stimulation in other areas of the body.